speaker-headshot

Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia

Dr. Alexander Fleming, an endocrinologist, is Founder and Executive Chairman of Kinexum, a strategic advisory firm. Following training at Emory and Vanderbilt and 4 years at NIH, from 1986-98 at the U.S. Food and Drug Administration, he was responsible for landmark approvals of the first statin, metformin, and other endocrine and metabolic therapies. He also was seconded to the World Health Organization from FDA and represented FDA on multiple expert working groups of the International Conference on Harmonization (ICH). He serves on multiple corporate, advisory, and editorial boards and is a member of the joint ADA-EASD diabetes technology working group, which regularly publishes consensus statements on those topics. Dr. Fleming coined the term, Metabesity, which refers to the constellation of major chronic diseases and the aging process itself, all which share common metabolic root causes and potential preventive therapies. He organized the first Congress on Metabesity in London in October 2017, followed by annual conferences since. Dr. Fleming founded in 2020 the not-for-profit Kitalys Institute as a means of producing Metabesity conferences and advancing interventions of any kind that can improve health and healthspan.